|
RCOR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.955000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.182400E-02 |
| Normal-vs-Stage2 |
2.386800E-01 |
| Normal-vs-Stage3 |
3.765900E-02 |
| Normal-vs-Stage4 |
5.172000E-02 |
| Stage1-vs-Stage2 |
1.628060E-02 |
| Stage1-vs-Stage3 |
1.412480E-04 |
| Stage1-vs-Stage4 |
5.172700E-04 |
| Stage2-vs-Stage3 |
6.891800E-01 |
| Stage2-vs-Stage4 |
5.752000E-01 |
| Stage3-vs-Stage4 |
7.807600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.077600E-01 |
| Normal-vs-AfricanAmerican |
7.020200E-01 |
| Normal-vs-Asian |
7.559200E-01 |
| Caucasian-vs-AfricanAmerican |
7.945600E-01 |
| Caucasian-vs-Asian |
6.822400E-01 |
| AfricanAmerican-vs-Asian |
6.291000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.097200E-01 |
| Normal-vs-Female |
3.084000E-01 |
| Male-vs-Female |
3.148500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.713400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.918800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.666400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.175200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.120200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.756200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.764600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.653900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.651400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.806000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.904600E-03 |
| Normal-vs-Grade 2 |
6.881900E-02 |
| Normal-vs-Grade 3 |
1.296560E-01 |
| Normal-vs-Grade 4 |
1.759140E-03 |
| Grade 1-vs-Grade 2 |
8.961700E-03 |
| Grade 1-vs-Grade 3 |
1.028000E-04 |
| Grade 1-vs-Grade 4 |
4.33440000002783E-06 |
| Grade 2-vs-Grade 3 |
5.555200E-04 |
| Grade 2-vs-Grade 4 |
3.23779999999996E-06 |
| Grade 3-vs-Grade 4 |
3.538000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.417000E-03 |
| Normal-vs-ccB subtype |
1.049150E-01 |
| ccA subtype-vs-ccB subtype |
2.16819999999673E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.674200E-01 |
| Normal-vs-N1 |
1.381850E-03 |
| N0-vs-N1 |
3.280100E-02 |
|
|
